(PRWEB) September 04, 2013
Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, will be hosting a complimentary seminar on “Robustness, Reproducibility and Risk Management; the Route to Successful Commercialisation.” The seminar will be held on Tuesday, Sept. 24, from 12:00 to 5:30 p.m. Central European Time at the Patheon facility in Bourgoin-Jallieu, France.
For the upcoming seminar, Patheon invited four scientific leaders to share their experiences and answer questions on successfully progressing through the development stages to commercialisation. Presentations will be provided by Patheon employees Romano Rivolta, Francois Berthier and Katherine Griotier, as well as Mike Dey from Claidmhor Pharma Ltd.
Through case studies and interactive presentations, the presenters will discuss how to build reliable quality into pharmaceutical products, looking at quality by design, scale-up and technology transfers. In addition, Katherine Griotier will present regulatory strategies. Contact Patheon to learn more about the upcoming seminar or to register.
About Patheon Inc.
Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.
Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.